Question 490
Developers launch AI tools without recording intended use, owners or risk acceptance. The internal audit team is asking for a reproducible control. Which diagnosis most closely fits the scenario?
Explanation
Correct Answer
Lifecycle controls cannot operate without a traceable inventory and approval history. This explains the observed weakness and why the proposed action matters: introduce an AI use-case register and risk approval gate before launch.
Incorrect Answers
The proposed cause describes a different problem: evidence retention controls fail to support traceability and oversight. In this case, the primary issue is that lifecycle controls cannot operate without a traceable inventory and approval history.
The proposed cause describes a different problem: the release process lacks a governed model-change control. In this case, the primary issue is that lifecycle controls cannot operate without a traceable inventory and approval history.
The proposed cause describes a different problem: original approval did not cover a materially different use and harm profile. In this case, the primary issue is that lifecycle controls cannot operate without a traceable inventory and approval history.